IMMUNE GLOBULIN

IMMUNE GLOBULIN was reported 8671 times

IMMUNE GLOBULIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRISOMY 12 2 0.5000
1 POWASSAN VIRUS ENCEPHALITIS 2 0.2222
2 MISLEADING LABORATORY TEST RESULT 10 0.1205
3 CONGENITAL MYASTHENIC SYNDROME 2 0.0952
4 NEONATAL HEPATOMEGALY 5 0.0893
5 BORRELIA TEST POSITIVE 5 0.0833
6 HEPATITIS E ANTIBODY POSITIVE 2 0.0571
7 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 3 0.0508
8 HEPATITIS B SURFACE ANTIBODY POSITIVE 14 0.0479
9 HEPATITIS B CORE ANTIBODY POSITIVE 18 0.0477
10 REFRACTORY ANAEMIA WITH RINGED SIDEROBLASTS 2 0.0455
11 ANTI A ANTIBODY POSITIVE 2 0.0364
12 ADENOVIRAL HEPATITIS 8 0.0340
13 NEONATAL TACHYCARDIA 5 0.0323
14 HAEMOLYTIC TRANSFUSION REACTION 2 0.0308
15 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 27 0.0217
16 CARDIAC SARCOIDOSIS 5 0.0216
17 BK POLYOMAVIRUS TEST POSITIVE 2 0.0208
18 TRANSFUSION-RELATED ACUTE LUNG INJURY 6 0.0195
19 Q FEVER 4 0.0189
20 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 6 0.0179
21 HEPATITIS B ANTIBODY POSITIVE 3 0.0160
22 ABDOMINAL MIGRAINE 1 0.0147
23 STIFF PERSON SYNDROME 5 0.0144
24 PELIOSIS HEPATIS 2 0.0139
25 ADENOVIRUS REACTIVATION 2 0.0139
26 ENANTHEMA 8 0.0139
27 VENOUS HAEMORRHAGE 4 0.0129
28 NEONATAL TACHYPNOEA 5 0.0121
29 ANTI-PLATELET ANTIBODY POSITIVE 2 0.0116
30 LIMB IMMOBILISATION 2 0.0108
31 STAPHYLOCOCCAL OSTEOMYELITIS 2 0.0108
32 PNEUMONIA ADENOVIRAL 2 0.0101
33 LICE INFESTATION 2 0.0095
34 DESMOID TUMOUR 2 0.0095
35 BODY HEIGHT BELOW NORMAL 6 0.0093
36 EXPOSURE TO FUNGUS 2 0.0093
37 AUTOIMMUNE NEPHRITIS 2 0.0091
38 SECONDARY IMMUNODEFICIENCY 11 0.0091
39 SHUNT INFECTION 2 0.0088
40 IMMUNODEFICIENCY COMMON VARIABLE 4 0.0082
41 RESPIRATORY TRACT INFECTION BACTERIAL 4 0.0080
42 VASCULAR ACCESS SITE COMPLICATION 2 0.0079
43 CYANOSIS NEONATAL 5 0.0078
44 LEIOMYOSARCOMA 3 0.0078
45 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 4 0.0076
46 DEATH OF RELATIVE 3 0.0074
47 HYPERADRENOCORTICISM 2 0.0073
48 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 10 0.0070
49 TRANSIENT ACANTHOLYTIC DERMATOSIS 2 0.0068
50 POOR DENTAL CONDITION 2 0.0068
51 ENTEROBACTER BACTERAEMIA 2 0.0066
52 ALLERGY TO ARTHROPOD STING 3 0.0066
53 ANTI-THYROID ANTIBODY POSITIVE 3 0.0066
54 ALLERGY TO PLANTS 3 0.0066
55 PNEUMONIA HAEMOPHILUS 3 0.0062
56 NOROVIRUS TEST POSITIVE 2 0.0062
57 INFUSION SITE URTICARIA 4 0.0060
58 AUTOIMMUNE PANCREATITIS 3 0.0059
59 SEPTIC ARTHRITIS STAPHYLOCOCCAL 2 0.0057
60 WHITE COAT HYPERTENSION 3 0.0055
61 CEREBRAL MASS EFFECT 2 0.0055
62 PILOERECTION 6 0.0055
63 BLOOD MAGNESIUM ABNORMAL 3 0.0054
64 SCLERODERMA RENAL CRISIS 2 0.0053
65 HEPATITIS B VIRUS TEST POSITIVE 2 0.0052
66 HERPES SIMPLEX REACTIVATION 2 0.0052
67 MYASTHENIC SYNDROME 4 0.0052
68 ENTEROCOCCAL SEPSIS 4 0.0049
69 HUMAN HERPESVIRUS 8 INFECTION 3 0.0049
70 UREAPLASMA INFECTION 2 0.0049
71 MENINGITIS ASEPTIC 22 0.0049
72 CELLULITIS STAPHYLOCOCCAL 3 0.0046
73 FUNGAL FOOT INFECTION 2 0.0046
74 INFECTION REACTIVATION 5 0.0044
75 BONE MARROW TOXICITY 5 0.0042
76 LABILE BLOOD PRESSURE 5 0.0042
77 EVANS SYNDROME 2 0.0041
78 BLOOD IMMUNOGLOBULIN G DECREASED 10 0.0040
79 VEIN COLLAPSE 3 0.0039
80 TRI-IODOTHYRONINE DECREASED 2 0.0038
81 PULMONARY MUCORMYCOSIS 2 0.0038
82 IMMUNE-MEDIATED NECROTISING MYOPATHY 2 0.0037
83 IMMUNOGLOBULINS DECREASED 5 0.0036
84 KLEBSIELLA SEPSIS 4 0.0035
85 DYSPRAXIA 2 0.0035
86 TRANSFUSION REACTION 3 0.0034
87 PNEUMOCOCCAL INFECTION 2 0.0034
88 CAMPYLOBACTER GASTROENTERITIS 2 0.0034
89 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 2 0.0034
90 JUVENILE IDIOPATHIC ARTHRITIS 8 0.0033
91 CEREBRAL TOXOPLASMOSIS 3 0.0032
92 BLOOD IMMUNOGLOBULIN A DECREASED 2 0.0031
93 LUNG TRANSPLANT REJECTION 2 0.0030
94 MARROW HYPERPLASIA 2 0.0029
95 HEPATIC NECROSIS 11 0.0029
96 VIRAL HAEMORRHAGIC CYSTITIS 2 0.0028
97 PANCREATIC MASS 3 0.0028
98 DYSHIDROTIC ECZEMA 2 0.0028
99 SOMATIC SYMPTOM DISORDER 3 0.0028
100 PALMOPLANTAR KERATODERMA 2 0.0028
101 CEREBRAL VENOUS THROMBOSIS 5 0.0028
102 SYMPTOM MASKED 2 0.0027
103 MIXED LIVER INJURY 8 0.0027
104 LIGAMENT INJURY 3 0.0026
105 MUCOSAL HAEMORRHAGE 3 0.0026
106 CUTANEOUS LUPUS ERYTHEMATOSUS 5 0.0026
107 PULMONARY MYCOSIS 2 0.0026
108 CHRONIC ALLOGRAFT NEPHROPATHY 2 0.0026
109 BLISTER INFECTED 2 0.0026
110 SUPERIOR SAGITTAL SINUS THROMBOSIS 2 0.0025
111 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
112 DYSBIOSIS 2 0.0024
113 VARICELLA ZOSTER VIRUS INFECTION 5 0.0024
114 ANTIBODY TEST POSITIVE 4 0.0024
115 CAMPYLOBACTER INFECTION 2 0.0024
116 SEPTIC EMBOLUS 2 0.0024
117 HEPATITIS A 2 0.0024
118 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 5 0.0023
119 LYMPHOCYTOSIS 5 0.0023
120 SLOW RESPONSE TO STIMULI 3 0.0023
121 HYPERLEUKOCYTOSIS 2 0.0023
122 CYTOMEGALOVIRUS VIRAEMIA 10 0.0022
123 PARVOVIRUS B19 INFECTION 2 0.0022
124 CANDIDA SEPSIS 2 0.0022
125 ANAPHYLACTOID REACTION 9 0.0022
126 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 5 0.0021
127 BRAIN STEM HAEMORRHAGE 2 0.0021
128 MYASTHENIA GRAVIS 17 0.0021
129 MENINGITIS BACTERIAL 3 0.0021
130 ADENOVIRUS INFECTION 6 0.0021
131 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
132 RHINOVIRUS INFECTION 8 0.0021
133 CYTOMEGALOVIRUS CHORIORETINITIS 4 0.0020
134 MYASTHENIA GRAVIS CRISIS 3 0.0020
135 IMPETIGO 3 0.0020
136 ABORTION THREATENED 1 0.0020
137 DEVICE RELATED SEPSIS 4 0.0020
138 CYSTITIS HAEMORRHAGIC 8 0.0020
139 ARTHRODESIS 2 0.0020
140 HEPATOSPLENOMEGALY 5 0.0019
141 MUCORMYCOSIS 5 0.0019
142 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
143 INTRACRANIAL VENOUS SINUS THROMBOSIS 2 0.0019
144 TOXOPLASMOSIS 2 0.0019
145 INFUSION SITE MASS 2 0.0018
146 OXYGEN THERAPY 3 0.0018
147 STAPHYLOCOCCAL SEPSIS 9 0.0018
148 IMMEDIATE POST-INJECTION REACTION 2 0.0018
149 ARTHROPOD STING 3 0.0018
150 LYME DISEASE 6 0.0018
151 BK VIRUS INFECTION 6 0.0018
152 HEREDITARY ANGIOEDEMA 19 0.0018
153 IMMUNE THROMBOCYTOPENIC PURPURA 5 0.0018
154 DERMATITIS EXFOLIATIVE GENERALISED 6 0.0017
155 EPIDIDYMITIS 2 0.0017
156 INFUSION RELATED REACTION 114 0.0017
157 RECTAL ULCER 2 0.0017
158 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
159 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
160 HYPOGAMMAGLOBULINAEMIA 11 0.0017
161 INFUSION SITE WARMTH 2 0.0016
162 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
163 CUTANEOUS T-CELL LYMPHOMA 2 0.0016
164 BRONCHIAL SECRETION RETENTION 2 0.0016
165 OBLITERATIVE BRONCHIOLITIS 2 0.0015
166 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
167 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
168 VULVOVAGINAL CANDIDIASIS 2 0.0015
169 MENINGITIS VIRAL 2 0.0015
170 ENTEROCOCCAL INFECTION 7 0.0014
171 VIRAEMIA 2 0.0014
172 LIVEDO RETICULARIS 3 0.0014
173 RENAL TUBULAR DISORDER 4 0.0014
174 CATAPLEXY 2 0.0014
175 CEREBELLAR HAEMORRHAGE 2 0.0014
176 INFUSION SITE INDURATION 2 0.0013
177 STEROID DIABETES 2 0.0013
178 SUPERINFECTION 2 0.0013
179 POLYARTHRITIS 7 0.0013
180 SERUM FERRITIN INCREASED 7 0.0013
181 COMPLICATIONS OF TRANSPLANTED KIDNEY 3 0.0013
182 REACTION TO EXCIPIENT 3 0.0013
183 MYOPATHY 11 0.0013
184 INFUSION SITE PRURITUS 4 0.0013
185 CUSHINGOID 4 0.0012
186 CRYPTOCOCCOSIS 2 0.0012
187 GLOMERULONEPHRITIS 3 0.0012
188 LYMPHOCYTE COUNT INCREASED 4 0.0012
189 VENOOCCLUSIVE LIVER DISEASE 6 0.0012
190 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
191 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
192 ENTEROBACTER INFECTION 2 0.0012
193 URINARY TRACT INFECTION BACTERIAL 3 0.0012
194 INFUSION SITE ERYTHEMA 10 0.0012
195 BRAIN ABSCESS 3 0.0012
196 HAEMOLYSIS 9 0.0012
197 RETINITIS 2 0.0012
198 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
199 VERTIGO POSITIONAL 2 0.0011
200 IMMUNOSUPPRESSION 10 0.0011
201 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
202 POLYMYOSITIS 2 0.0011
203 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
204 TRANSPLANT DYSFUNCTION 2 0.0011
205 HEPATOMEGALY 11 0.0011
206 INFUSION SITE SWELLING 7 0.0011
207 TACHYPNOEA 15 0.0011
208 URTICARIA 183 0.0011
209 TOXIC SKIN ERUPTION 11 0.0011
210 CYTOMEGALOVIRUS INFECTION 18 0.0011
211 CATHETER PLACEMENT 2 0.0011
212 SERUM SICKNESS 3 0.0011
213 CHRONIC LYMPHOCYTIC LEUKAEMIA 5 0.0011
214 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
215 OSTEOPOROTIC FRACTURE 2 0.0010
216 RETINAL VEIN OCCLUSION 3 0.0010
217 HEPATIC MASS 2 0.0010
218 GUILLAIN-BARRE SYNDROME 5 0.0010
219 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
220 PYELONEPHRITIS ACUTE 2 0.0010
221 PNEUMONIA FUNGAL 4 0.0010
222 SUSPECTED COUNTERFEIT PRODUCT 4 0.0010
223 BACTERAEMIA 12 0.0010
224 INFUSION SITE REACTION 3 0.0010
225 HYPERAMMONAEMIA 5 0.0010
226 MUSCLE HAEMORRHAGE 4 0.0010
227 HEPATITIS B 6 0.0010
228 EMBOLISM VENOUS 3 0.0010
229 CEREBRAL ISCHAEMIA 5 0.0010
230 MULTIPLE-DRUG RESISTANCE 3 0.0010
231 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
232 DERMATITIS ALLERGIC 12 0.0010
233 VASCULAR OCCLUSION 2 0.0009
234 FEBRILE BONE MARROW APLASIA 4 0.0009
235 HYPERPHOSPHATAEMIA 2 0.0009
236 CHEILITIS 5 0.0009
237 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8 0.0009
238 ACARODERMATITIS 1 0.0009
239 ACINETOBACTER INFECTION 1 0.0009
240 ORAL CANDIDIASIS 12 0.0009
241 RESPIRATORY RATE INCREASED 8 0.0009
242 MENINGITIS 6 0.0009
243 ECCHYMOSIS 6 0.0009
244 PUSTULAR PSORIASIS 3 0.0009
245 LEFT VENTRICULAR FAILURE 3 0.0009
246 CYTOMEGALOVIRUS COLITIS 2 0.0009
247 ENCEPHALITIS 6 0.0009
248 METHAEMOGLOBINAEMIA 2 0.0009
249 NECK SURGERY 2 0.0009
250 THROAT TIGHTNESS 23 0.0008
251 LYMPHOPENIA 12 0.0008
252 PULMONARY INFARCTION 2 0.0008
253 HAEMORRHAGIC DIATHESIS 3 0.0008
254 PRODUCT SUPPLY ISSUE 6 0.0008
255 LONG QT SYNDROME 2 0.0008
256 DIABETES INSIPIDUS 2 0.0008
257 PREMATURE RUPTURE OF MEMBRANES 2 0.0008
258 LEUKOENCEPHALOPATHY 3 0.0008
259 TACHYARRHYTHMIA 2 0.0008
260 VENOOCCLUSIVE DISEASE 2 0.0008
261 KLEBSIELLA INFECTION 4 0.0008
262 DERMATOMYOSITIS 2 0.0008
263 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
264 NOCARDIOSIS 2 0.0008
265 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
266 DRUG TITRATION ERROR 2 0.0008
267 POOR VENOUS ACCESS 8 0.0008
268 ACTINIC KERATOSIS 2 0.0008
269 URINE OUTPUT INCREASED 2 0.0008
270 PSYCHOMOTOR SKILLS IMPAIRED 2 0.0008
271 CYANOSIS 12 0.0008
272 ASPERGILLUS INFECTION 5 0.0008
273 EXFOLIATIVE RASH 2 0.0008
274 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
275 ATRIAL FLUTTER 6 0.0008
276 BLOOD POTASSIUM ABNORMAL 2 0.0007
277 TRANSPLANT REJECTION 6 0.0007
278 SKIN PAPILLOMA 3 0.0007
279 PALLOR 20 0.0007
280 LIP BLISTER 2 0.0007
281 BLOOD PHOSPHORUS INCREASED 2 0.0007
282 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
283 IMMUNE-MEDIATED MYOSITIS 2 0.0007
284 LUNG CONSOLIDATION 2 0.0007
285 BRAIN OEDEMA 9 0.0007
286 CANDIDA INFECTION 12 0.0007
287 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
288 NEUROLOGICAL SYMPTOM 4 0.0007
289 PARAESTHESIA ORAL 10 0.0007
290 ESCHERICHIA SEPSIS 2 0.0007
291 RALES 4 0.0007
292 SUBARACHNOID HAEMORRHAGE 7 0.0007
293 ONYCHOMYCOSIS 3 0.0007
294 STRIDOR 2 0.0007
295 PURPURA 6 0.0007
296 WHEELCHAIR USER 3 0.0007
297 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
298 HAEMOLYTIC ANAEMIA 6 0.0007
299 BRAIN HERNIATION 2 0.0007
300 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
301 PROSTATITIS 2 0.0007
302 ISCHAEMIA 3 0.0007
303 INTRACARDIAC THROMBUS 2 0.0007
304 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
305 PORTAL HYPERTENSION 2 0.0006
306 CHILLS 76 0.0006
307 PANCYTOPENIA 36 0.0006
308 BODY TEMPERATURE INCREASED 13 0.0006
309 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
310 IRIDOCYCLITIS 2 0.0006
311 LIP SWELLING 21 0.0006
312 POLYMYALGIA RHEUMATICA 2 0.0006
313 NEPHROPATHY TOXIC 7 0.0006
314 LYMPHADENOPATHY 22 0.0006
315 INFUSION SITE PAIN 8 0.0006
316 SHOCK HAEMORRHAGIC 5 0.0006
317 BACTERIAL SEPSIS 2 0.0006
318 SUSPECTED COVID-19 2 0.0006
319 PROTEIN URINE PRESENT 3 0.0006
320 SALIVARY HYPERSECRETION 6 0.0006
321 VEIN DISORDER 3 0.0006
322 SPLENOMEGALY 7 0.0006
323 BACTERIAL INFECTION 11 0.0006
324 B-CELL LYMPHOMA 2 0.0006
325 FACIAL PARALYSIS 5 0.0006
326 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
327 HAEMATOMA 15 0.0006
328 SEPTIC SHOCK 25 0.0006
329 TUMOUR LYSIS SYNDROME 5 0.0006
330 PNEUMONIA ASPIRATION 14 0.0006
331 DECREASED ACTIVITY 6 0.0006
332 PYODERMA GANGRENOSUM 2 0.0006
333 DERMATITIS BULLOUS 4 0.0006
334 LUPUS-LIKE SYNDROME 5 0.0006
335 PATHOGEN RESISTANCE 5 0.0005
336 INTESTINAL ISCHAEMIA 3 0.0005
337 PNEUMONIA BACTERIAL 5 0.0005
338 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
339 HYPOPHOSPHATAEMIA 4 0.0005
340 NECROSIS 3 0.0005
341 HYDRONEPHROSIS 4 0.0005
342 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
343 PEMPHIGOID 4 0.0005
344 GENERALISED ERYTHEMA 3 0.0005
345 THROMBOCYTOPENIA 59 0.0005
346 HYPERTONIA 3 0.0005
347 INSURANCE ISSUE 8 0.0005
348 CHOLESTASIS 10 0.0005
349 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
350 PERICARDIAL EFFUSION 12 0.0005
351 THERAPY NON-RESPONDER 23 0.0005
352 PHARYNGEAL SWELLING 5 0.0005
353 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
354 LIGAMENT SPRAIN 5 0.0005
355 OBESITY 8 0.0005
356 POLYNEUROPATHY 6 0.0005
357 AZOTAEMIA 2 0.0005
358 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
359 HEPATIC FAILURE 15 0.0005
360 INJECTION SITE VESICLES 3 0.0005
361 TACHYCARDIA 44 0.0005
362 ADRENAL INSUFFICIENCY 6 0.0005
363 CONJUNCTIVITIS 9 0.0005
364 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
365 INFUSION SITE EXTRAVASATION 3 0.0005
366 ECZEMA 25 0.0005
367 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 26 0.0005
368 LIP OEDEMA 2 0.0005
369 HEMIPARESIS 8 0.0005
370 RESPIRATORY DISTRESS 13 0.0005
371 ACUTE RESPIRATORY FAILURE 9 0.0005
372 HYPOAESTHESIA ORAL 7 0.0005
373 APHASIA 14 0.0005
374 OCULAR ICTERUS 2 0.0005
375 LEUKOPENIA 23 0.0005
376 CORONAVIRUS INFECTION 3 0.0005
377 GINGIVAL SWELLING 2 0.0005
378 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
379 DRUG ERUPTION 8 0.0005
380 STEVENS-JOHNSON SYNDROME 10 0.0004
381 CYTOKINE RELEASE SYNDROME 9 0.0004
382 GOUT 8 0.0004
383 OCULAR DISCOMFORT 5 0.0004
384 PRURITUS 168 0.0004
385 IMMUNE THROMBOCYTOPENIA 2 0.0004
386 DROOLING 3 0.0004
387 INTENTIONAL PRODUCT USE ISSUE 38 0.0004
388 ROSACEA 2 0.0004
389 OXYGEN SATURATION DECREASED 24 0.0004
390 RASH PRURITIC 23 0.0004
391 SKIN ABRASION 2 0.0004
392 PULMONARY EMBOLISM 40 0.0004
393 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
394 KIDNEY TRANSPLANT REJECTION 2 0.0004
395 PRODUCT PRESCRIBING ISSUE 9 0.0004
396 AUTOIMMUNE DISORDER 4 0.0004
397 FOOT OPERATION 2 0.0004
398 PULMONARY MASS 6 0.0004
399 ILEUS 5 0.0004
400 RASH PAPULAR 9 0.0004
401 PATHOLOGICAL FRACTURE 2 0.0004
402 HAEMODYNAMIC INSTABILITY 3 0.0004
403 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
404 ISCHAEMIC STROKE 7 0.0004
405 LIPASE INCREASED 3 0.0004
406 ABDOMINAL INFECTION 1 0.0004
407 FUNGAL INFECTION 13 0.0004
408 ENDOCARDITIS 2 0.0004
409 FAILURE TO THRIVE 2 0.0004
410 C-REACTIVE PROTEIN INCREASED 14 0.0004
411 PETECHIAE 4 0.0004
412 CHEST DISCOMFORT 39 0.0004
413 BLOOD LACTIC ACID INCREASED 2 0.0004
414 HAEMATURIA 13 0.0004
415 RASH 165 0.0004
416 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
417 ADVERSE REACTION 5 0.0004
418 PYREXIA 129 0.0004
419 OVERWEIGHT 2 0.0004
420 PHOTOPHOBIA 7 0.0004
421 JAUNDICE 10 0.0004
422 NORMAL NEWBORN 2 0.0004
423 SKIN LACERATION 4 0.0004
424 ASPIRATION 4 0.0004
425 PERIPHERAL COLDNESS 5 0.0004
426 DEAFNESS UNILATERAL 2 0.0004
427 VIRAL INFECTION 12 0.0004
428 HYPERTENSIVE CRISIS 4 0.0004
429 STREPTOCOCCAL INFECTION 2 0.0004
430 HYPOMAGNESAEMIA 5 0.0004
431 INTRACRANIAL PRESSURE INCREASED 2 0.0004
432 FEELING HOT 22 0.0004
433 SEPSIS 40 0.0004
434 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
435 EYE INFECTION 4 0.0004
436 REBOUND EFFECT 4 0.0004
437 SKIN TOXICITY 2 0.0004
438 PREMATURE LABOUR 2 0.0004
439 HEPATOCELLULAR INJURY 5 0.0004
440 NEUTROPHILIA 2 0.0004
441 GRANULOCYTOPENIA 2 0.0004
442 MYOCARDITIS 4 0.0003
443 MULTI-ORGAN FAILURE 6 0.0003
444 FEBRILE NEUTROPENIA 23 0.0003
445 MOUTH SWELLING 2 0.0003
446 HYPERVENTILATION 2 0.0003
447 ANAPHYLACTIC REACTION 19 0.0003
448 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
449 DYSPHONIA 20 0.0003
450 GROIN PAIN 3 0.0003
451 FACIAL PAIN 3 0.0003
452 PROTHROMBIN TIME PROLONGED 2 0.0003
453 SYMPTOM RECURRENCE 2 0.0003
454 SYNOVITIS 6 0.0003
455 GASTROENTERITIS VIRAL 6 0.0003
456 FOETAL GROWTH RESTRICTION 2 0.0003
457 GENERALISED OEDEMA 4 0.0003
458 SCOLIOSIS 2 0.0003
459 BASAL CELL CARCINOMA 5 0.0003
460 FLANK PAIN 3 0.0003
461 SECRETION DISCHARGE 4 0.0003
462 SWELLING OF EYELID 2 0.0003
463 ABDOMINAL ADHESIONS 1 0.0003
464 PHOTOPSIA 2 0.0003
465 HAEMATOTOXICITY 3 0.0003
466 HEPATOTOXICITY 7 0.0003
467 SCREAMING 2 0.0003
468 HEPATIC CYTOLYSIS 4 0.0003
469 SCIATICA 5 0.0003
470 ABSCESS 5 0.0003
471 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
472 ENTERITIS 2 0.0003
473 HYPOXIA 11 0.0003
474 HAEMOGLOBIN ABNORMAL 2 0.0003
475 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
476 BRONCHITIS 23 0.0003
477 DIPLOPIA 8 0.0003
478 THROMBOTIC MICROANGIOPATHY 3 0.0003
479 HERPES SIMPLEX 2 0.0003
480 RESPIRATORY TRACT INFECTION 8 0.0003
481 POLYP 2 0.0003
482 THERAPY CHANGE 3 0.0003
483 WALKING AID USER 2 0.0003
484 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
485 BLOOD PRESSURE ABNORMAL 6 0.0003
486 BLOOD BILIRUBIN INCREASED 8 0.0003
487 EYELID PTOSIS 3 0.0003
488 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
489 DEEP VEIN THROMBOSIS 19 0.0003
490 ANAEMIA 55 0.0003
491 SWOLLEN TONGUE 9 0.0003
492 MENTAL STATUS CHANGES 8 0.0003
493 FEELING COLD 8 0.0003
494 WHEEZING 17 0.0003
495 DEFAECATION URGENCY 2 0.0003
496 NEUROTOXICITY 5 0.0003
497 ENCEPHALOPATHY 7 0.0003
498 PAPULE 2 0.0003
499 CYSTITIS 9 0.0003
500 BLOOD PRESSURE INCREASED 43 0.0003
501 PANIC REACTION 2 0.0003
502 BACK INJURY 3 0.0003
503 PULMONARY THROMBOSIS 3 0.0003
504 LIVER FUNCTION TEST ABNORMAL 8 0.0003
505 RASH PUSTULAR 2 0.0003
506 HYPERGLYCAEMIA 10 0.0003
507 HEADACHE 171 0.0003
508 RASH GENERALISED 7 0.0003
509 VENTRICULAR FIBRILLATION 3 0.0003
510 ARTHROPOD BITE 2 0.0003
511 INTERSTITIAL LUNG DISEASE 13 0.0003
512 IMMUNODEFICIENCY 4 0.0003
513 PULMONARY OEDEMA 12 0.0003
514 ACUTE KIDNEY INJURY 41 0.0003
515 ERYTHEMA 55 0.0003
516 MUCOSAL INFLAMMATION 7 0.0003
517 STATUS EPILEPTICUS 3 0.0003
518 HYPERSENSITIVITY 49 0.0003
519 DERMATITIS CONTACT 3 0.0003
520 ILLNESS 27 0.0003
521 HYPERTHERMIA 2 0.0003
522 GLAUCOMA 5 0.0003
523 APHTHOUS ULCER 2 0.0003
524 CAESAREAN SECTION 3 0.0003
525 VASCULITIS 3 0.0003
526 LUNG INFECTION 4 0.0003
527 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
528 ACUTE MYELOID LEUKAEMIA 4 0.0003
529 SINUS DISORDER 5 0.0003
530 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
531 NASAL DISCOMFORT 2 0.0003
532 BACK DISORDER 4 0.0002
533 POST PROCEDURAL INFECTION 2 0.0002
534 DECUBITUS ULCER 2 0.0002
535 THROAT IRRITATION 11 0.0002
536 CYTOPENIA 3 0.0002
537 PLATELET COUNT DECREASED 26 0.0002
538 ESCHERICHIA INFECTION 2 0.0002
539 SPINAL COMPRESSION FRACTURE 2 0.0002
540 ACUTE CORONARY SYNDROME 2 0.0002
541 MIGRAINE 23 0.0002
542 EMBOLISM 2 0.0002
543 ASCITES 7 0.0002
544 MUSCULAR WEAKNESS 27 0.0002
545 SENSATION OF FOREIGN BODY 2 0.0002
546 MOUTH ULCERATION 5 0.0002
547 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
548 SKIN EXFOLIATION 20 0.0002
549 CARDIOVASCULAR DISORDER 6 0.0002
550 HYPERTENSION 50 0.0002
551 NEUTROPENIA 32 0.0002
552 INFECTION 34 0.0002
553 HEPATITIS 6 0.0002
554 HYPOTENSION 47 0.0002
555 ANURIA 2 0.0002
556 HIATUS HERNIA 3 0.0002
557 BLISTER 13 0.0002
558 HYSTERECTOMY 2 0.0002
559 SWELLING FACE 15 0.0002
560 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
561 GASTRITIS 6 0.0002
562 HEART RATE DECREASED 8 0.0002
563 IMMUNE SYSTEM DISORDER 3 0.0002
564 MELAENA 5 0.0002
565 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
566 RASH MACULO-PAPULAR 5 0.0002
567 GASTROINTESTINAL INFECTION 2 0.0002
568 ANAL INCONTINENCE 2 0.0002
569 OEDEMA 12 0.0002
570 HEAD INJURY 7 0.0002
571 CONDITION AGGRAVATED 67 0.0002
572 IMPAIRED GASTRIC EMPTYING 3 0.0002
573 PRODUCT AVAILABILITY ISSUE 5 0.0002
574 ACUTE HEPATIC FAILURE 3 0.0002
575 DYSPNOEA 124 0.0002
576 INCREASED TENDENCY TO BRUISE 2 0.0002
577 IRON DEFICIENCY ANAEMIA 2 0.0002
578 COVID-19 38 0.0002
579 PRODUCT DISTRIBUTION ISSUE 2 0.0002
580 HUNGER 3 0.0002
581 COORDINATION ABNORMAL 3 0.0002
582 HEPATIC STEATOSIS 4 0.0002
583 APPENDICITIS 2 0.0002
584 EPISTAXIS 16 0.0002
585 SKIN REACTION 3 0.0002
586 OSTEOARTHRITIS 9 0.0002
587 HEART RATE INCREASED 21 0.0002
588 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
589 SPUTUM DISCOLOURED 2 0.0002
590 GAIT INABILITY 7 0.0002
591 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
592 MYELODYSPLASTIC SYNDROME 3 0.0002
593 HYPERCHOLESTEROLAEMIA 2 0.0002
594 DRUG INTOLERANCE 20 0.0002
595 HYPOKINESIA 3 0.0002
596 FLUID OVERLOAD 3 0.0002
597 NEURALGIA 5 0.0002
598 CEREBRAL INFARCTION 5 0.0002
599 HAEMOGLOBIN DECREASED 21 0.0002
600 INFLAMMATORY BOWEL DISEASE 2 0.0002
601 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
602 CARDIOMYOPATHY 3 0.0002
603 URINARY INCONTINENCE 6 0.0002
604 HAEMATOCRIT DECREASED 4 0.0002
605 CATARACT 12 0.0002
606 INABILITY TO AFFORD MEDICATION 2 0.0002
607 DYSPHAGIA 19 0.0002
608 CHEST PAIN 37 0.0002
609 THROMBOSIS 16 0.0002
610 FULL BLOOD COUNT DECREASED 4 0.0002
611 OSTEOPENIA 3 0.0002
612 HYPOTHERMIA 2 0.0002
613 FLUSHING 20 0.0002
614 DRUG LEVEL DECREASED 2 0.0002
615 MOTOR DYSFUNCTION 2 0.0002
616 SKIN DISCOLOURATION 9 0.0002
617 BLOOD PRESSURE DECREASED 13 0.0002
618 CEREBRAL HAEMORRHAGE 7 0.0002
619 SINUSITIS 20 0.0002
620 PHARYNGEAL OEDEMA 3 0.0002
621 HYPOKALAEMIA 9 0.0002
622 DEVICE RELATED INFECTION 3 0.0002
623 THERAPY CESSATION 10 0.0002
624 MYELOSUPPRESSION 7 0.0002
625 MUSCULOSKELETAL CHEST PAIN 3 0.0002
626 RENAL DISORDER 9 0.0002
627 EXPOSURE DURING PREGNANCY 12 0.0002
628 TREMOR 32 0.0002
629 VENTRICULAR EXTRASYSTOLES 2 0.0002
630 THERAPY PARTIAL RESPONDER 3 0.0002
631 PULMONARY HYPERTENSION 4 0.0002
632 TENDERNESS 2 0.0002
633 BONE DENSITY DECREASED 6 0.0002
634 WEIGHT FLUCTUATION 2 0.0002
635 HEPATIC ENZYME INCREASED 13 0.0002
636 SEIZURE 22 0.0002
637 GASTROINTESTINAL DISORDER 17 0.0002
638 INCONTINENCE 2 0.0002
639 SUDDEN DEATH 2 0.0002
640 COMA 9 0.0002
641 CEREBROVASCULAR ACCIDENT 32 0.0002
642 PERIPHERAL SWELLING 29 0.0002
643 URINARY TRACT INFECTION 32 0.0002
644 BODY HEIGHT DECREASED 2 0.0002
645 COUGH 52 0.0002
646 PRURITUS GENERALISED 4 0.0002
647 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
648 BIPOLAR DISORDER 2 0.0002
649 MUSCULOSKELETAL STIFFNESS 16 0.0002
650 WOUND INFECTION 2 0.0002
651 HAEMORRHAGE 19 0.0002
652 PHOTOSENSITIVITY REACTION 3 0.0002
653 TRANSAMINASES INCREASED 4 0.0002
654 NERVE INJURY 2 0.0002
655 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
656 PNEUMONIA 58 0.0002
657 INJECTION SITE PRURITUS 12 0.0002
658 NECK PAIN 10 0.0002
659 HYPERHIDROSIS 23 0.0002
660 SKIN INFECTION 2 0.0002
661 RESPIRATORY FAILURE 13 0.0002
662 FACE OEDEMA 3 0.0002
663 CHROMATURIA 4 0.0002
664 FLUID RETENTION 9 0.0002
665 SCAB 2 0.0002
666 VOMITING 82 0.0002
667 INFLAMMATION 9 0.0002
668 HERPES ZOSTER 10 0.0002
669 SHOCK 4 0.0002
670 GASTRIC HAEMORRHAGE 2 0.0002
671 PRODUCT SUBSTITUTION ISSUE 10 0.0002
672 MUSCLE TWITCHING 4 0.0002
673 BACK PAIN 40 0.0002
674 ELECTROLYTE IMBALANCE 2 0.0002
675 NEUTROPHIL COUNT DECREASED 7 0.0002
676 EOSINOPHILIA 3 0.0002
677 OFF LABEL USE 149 0.0002
678 NASAL CONGESTION 10 0.0002
679 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
680 ACUTE MYOCARDIAL INFARCTION 5 0.0002
681 COVID-19 PNEUMONIA 2 0.0002
682 BLOOD IRON DECREASED 2 0.0002
683 ATAXIA 2 0.0002
684 NAUSEA 133 0.0002
685 HYPERLIPIDAEMIA 2 0.0002
686 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
687 OSTEOMYELITIS 3 0.0002
688 PRODUCT USE IN UNAPPROVED INDICATION 41 0.0002
689 PRESYNCOPE 4 0.0002
690 PLEURAL EFFUSION 10 0.0002
691 MUSCLE SPASMS 30 0.0002
692 RESPIRATORY DEPRESSION 2 0.0002
693 LIVER INJURY 4 0.0002
694 MUSCLE SPASTICITY 2 0.0002
695 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
696 SMALL INTESTINAL OBSTRUCTION 2 0.0002
697 SPINAL OPERATION 2 0.0002
698 ASTHENIA 61 0.0002
699 EYE SWELLING 6 0.0002
700 PHARYNGITIS 2 0.0002
701 MENTAL DISORDER 7 0.0002
702 DYSPNOEA EXERTIONAL 6 0.0002
703 CELLULITIS 8 0.0002
704 HYPOCALCAEMIA 3 0.0002
705 ANGIOEDEMA 7 0.0002
706 INFLUENZA LIKE ILLNESS 13 0.0002
707 CARDIAC ARREST 13 0.0002
708 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
709 OEDEMA PERIPHERAL 19 0.0002
710 ROTATOR CUFF SYNDROME 2 0.0002
711 PLASMA CELL MYELOMA 6 0.0002
712 ORAL HERPES 3 0.0002
713 SKIN FISSURES 3 0.0002
714 SEDATION 4 0.0002
715 BEDRIDDEN 2 0.0002
716 RENAL FAILURE 20 0.0002
717 AGITATION 11 0.0001
718 UVEITIS 2 0.0001
719 DISEASE RECURRENCE 7 0.0001
720 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
721 OSTEOPOROSIS 6 0.0001
722 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
723 ATRIAL FIBRILLATION 14 0.0001
724 RASH MACULAR 5 0.0001
725 LUNG DISORDER 7 0.0001
726 DEVICE OCCLUSION 2 0.0001
727 BLINDNESS UNILATERAL 2 0.0001
728 EATING DISORDER 3 0.0001
729 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
730 JOINT INJURY 3 0.0001
731 BRONCHOSPASM 2 0.0001
732 THERAPY INTERRUPTED 10 0.0001
733 RED BLOOD CELL COUNT DECREASED 4 0.0001
734 SUBDURAL HAEMATOMA 2 0.0001
735 SKIN CANCER 3 0.0001
736 IMPAIRED QUALITY OF LIFE 2 0.0001
737 MALAISE 61 0.0001
738 PRODUCT DISPENSING ERROR 3 0.0001
739 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
740 CRYING 5 0.0001
741 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
742 DYSSTASIA 4 0.0001
743 BONE PAIN 8 0.0001
744 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
745 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
746 DEHYDRATION 18 0.0001
747 DIARRHOEA 87 0.0001
748 HEPATIC FUNCTION ABNORMAL 5 0.0001
749 HAEMORRHAGE INTRACRANIAL 2 0.0001
750 BLOOD POTASSIUM DECREASED 4 0.0001
751 PANCREATITIS 7 0.0001
752 DRUG INTERACTION 21 0.0001
753 BLOOD COUNT ABNORMAL 2 0.0001
754 SYNCOPE 13 0.0001
755 LYMPHOMA 2 0.0001
756 LIMB DISCOMFORT 4 0.0001
757 TREATMENT NONCOMPLIANCE 7 0.0001
758 BRAIN FOG 2 0.0001
759 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
760 RESPIRATORY TRACT CONGESTION 2 0.0001
761 HALLUCINATION, AUDITORY 2 0.0001
762 PREMATURE DELIVERY 2 0.0001
763 RASH ERYTHEMATOUS 6 0.0001
764 BLOOD PRESSURE FLUCTUATION 3 0.0001
765 FATIGUE 97 0.0001
766 NIGHT SWEATS 4 0.0001
767 EYE PAIN 7 0.0001
768 MENTAL IMPAIRMENT 3 0.0001
769 LACTIC ACIDOSIS 4 0.0001
770 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
771 BLINDNESS 5 0.0001
772 STAPHYLOCOCCAL INFECTION 4 0.0001
773 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
774 COAGULOPATHY 2 0.0001
775 AGGRESSION 6 0.0001
776 OROPHARYNGEAL PAIN 11 0.0001
777 TYPE 2 DIABETES MELLITUS 4 0.0001
778 RENAL FAILURE ACUTE 5 0.0001
779 LOSS OF CONSCIOUSNESS 15 0.0001
780 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
781 VISION BLURRED 16 0.0001
782 UNRESPONSIVE TO STIMULI 3 0.0001
783 BALANCE DISORDER 10 0.0001
784 PARAESTHESIA 18 0.0001
785 CONTUSION 11 0.0001
786 HYPERKALAEMIA 4 0.0001
787 COLD SWEAT 2 0.0001
788 HEAD DISCOMFORT 2 0.0001
789 LIVER DISORDER 5 0.0001
790 GALLBLADDER DISORDER 2 0.0001
791 ABDOMINAL PAIN UPPER 23 0.0001
792 DRUG INEFFECTIVE 147 0.0001
793 TOOTHACHE 2 0.0001
794 LIMB INJURY 3 0.0001
795 RESTLESS LEGS SYNDROME 2 0.0001
796 PANIC ATTACK 4 0.0001
797 SKIN LESION 3 0.0001
798 RESTLESSNESS 4 0.0001
799 TINNITUS 5 0.0001
800 DIVERTICULITIS 3 0.0001
801 ARTHRALGIA 45 0.0001
802 AGRANULOCYTOSIS 2 0.0001
803 SWELLING 10 0.0001
804 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
805 HYPONATRAEMIA 6 0.0001
806 HEPATIC CIRRHOSIS 2 0.0001
807 DYSARTHRIA 4 0.0001
808 ABORTION INDUCED 1 0.0001
809 ASTHMA 12 0.0001
810 INTESTINAL OBSTRUCTION 4 0.0001
811 ARRHYTHMIA 5 0.0001
812 FOOT FRACTURE 2 0.0001
813 OCULAR HYPERAEMIA 5 0.0001
814 NEUROPATHY PERIPHERAL 10 0.0001
815 PRODUCTIVE COUGH 5 0.0001
816 ANGINA PECTORIS 3 0.0001
817 SOMNOLENCE 21 0.0001
818 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
819 ABDOMINAL PAIN 24 0.0001
820 PAIN 63 0.0001
821 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
822 WEIGHT DECREASED 28 0.0001
823 RESPIRATORY DISORDER 3 0.0001
824 SPINAL FRACTURE 2 0.0001
825 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
826 STOMATITIS 6 0.0001
827 FEEDING DISORDER 2 0.0001
828 TASTE DISORDER 2 0.0001
829 BONE MARROW FAILURE 2 0.0001
830 DISCOMFORT 6 0.0001
831 RIB FRACTURE 2 0.0001
832 TREATMENT FAILURE 8 0.0001
833 NERVOUS SYSTEM DISORDER 3 0.0001
834 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
835 ABDOMINAL DISTENSION 10 0.0001
836 DERMATITIS 2 0.0001
837 SPEECH DISORDER 5 0.0001
838 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
839 TOXICITY TO VARIOUS AGENTS 16 0.0001
840 HALLUCINATION, VISUAL 2 0.0001
841 DECREASED APPETITE 22 0.0001
842 BRADYCARDIA 5 0.0001
843 DIZZINESS 47 0.0001
844 METABOLIC ACIDOSIS 3 0.0001
845 RETCHING 2 0.0001
846 WEIGHT INCREASED 21 0.0001
847 MOVEMENT DISORDER 3 0.0001
848 IRRITABLE BOWEL SYNDROME 2 0.0001
849 FALL 31 0.0001
850 RECTAL HAEMORRHAGE 4 0.0001
851 RHINORRHOEA 6 0.0001
852 BLOOD CREATININE INCREASED 6 0.0001
853 PRODUCT DOSE OMISSION ISSUE 27 0.0001
854 FEELING ABNORMAL 22 0.0001
855 PAIN IN EXTREMITY 27 0.0001
856 EYE PRURITUS 3 0.0001
857 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
858 ARTHRITIS 7 0.0001
859 PANCREATITIS ACUTE 2 0.0001
860 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
861 MEMORY IMPAIRMENT 12 0.0001
862 LETHARGY 5 0.0001
863 HYPOAESTHESIA 13 0.0001
864 ADVERSE EVENT 8 0.0001
865 NASOPHARYNGITIS 16 0.0001
866 MYOCARDIAL INFARCTION 15 0.0001
867 BLOOD CHOLESTEROL INCREASED 4 0.0001
868 COGNITIVE DISORDER 4 0.0001
869 HOSPITALISATION 13 0.0001
870 DISEASE PROGRESSION 10 0.0001
871 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
872 MOBILITY DECREASED 6 0.0001
873 ABDOMINAL DISCOMFORT 14 0.0001
874 RENAL IMPAIRMENT 7 0.0001
875 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
876 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
877 LOCALISED INFECTION 2 0.0001
878 FIBROMYALGIA 2 0.0001
879 PRODUCT QUALITY ISSUE 11 0.0001
880 CONFUSIONAL STATE 13 0.0001
881 HAEMATEMESIS 2 0.0001
882 HYPOPHAGIA 2 0.0001
883 DRUG RESISTANCE 2 0.0001
884 ANAPHYLACTIC SHOCK 2 0.0001
885 SKIN ULCER 2 0.0001
886 PALPITATIONS 9 0.0001
887 MYALGIA 13 0.0001
888 JOINT STIFFNESS 2 0.0001
889 DISORIENTATION 3 0.0001
890 EAR INFECTION 2 0.0001
891 CARDIAC DISORDER 7 0.0001
892 DISTURBANCE IN ATTENTION 4 0.0001
893 FREQUENT BOWEL MOVEMENTS 2 0.0001
894 PNEUMONITIS 2 0.0001
895 RESPIRATORY ARREST 2 0.0001
896 INJECTION SITE ERYTHEMA 9 0.0001
897 ABNORMAL DREAMS 2 0.0001
898 ARTHROPATHY 4 0.0001
899 WOUND 2 0.0001
900 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
901 ANXIETY 20 0.0001
902 NEEDLE ISSUE 2 0.0001
903 LABORATORY TEST ABNORMAL 2 0.0001
904 IRRITABILITY 4 0.0001
905 PREMATURE BABY 2 0.0001
906 HALLUCINATION 5 0.0001
907 THERAPEUTIC RESPONSE DECREASED 4 0.0001
908 DIABETES MELLITUS 5 0.0001
909 NEPHROLITHIASIS 3 0.0001
910 VISUAL IMPAIRMENT 8 0.0001
911 PRODUCT USE ISSUE 12 0.0001
912 DRUG-INDUCED LIVER INJURY 2 0.0001
913 INFLUENZA 7 0.0001
914 MULTIPLE SCLEROSIS 3 0.0001
915 GAIT DISTURBANCE 12 0.0001
916 INJECTION SITE BRUISING 5 0.0001
917 CARDIAC FAILURE 5 0.0001
918 DRY MOUTH 5 0.0001
919 DYSPEPSIA 6 0.0001
920 IMPAIRED HEALING 2 0.0001
921 EYE DISORDER 2 0.0001
922 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
923 VISUAL ACUITY REDUCED 2 0.0001
924 EXPIRED PRODUCT ADMINISTERED 2 0.0001
925 DRY EYE 3 0.0001
926 SKIN DISORDER 2 0.0001
927 INJECTION SITE REACTION 4 0.0001
928 BURNING SENSATION 4 0.0001
929 DRUG WITHDRAWAL SYNDROME 5 0.0001
930 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
931 UNDERDOSE 4 0.0001
932 HAEMATOCHEZIA 3 0.0001
933 DYSURIA 2 0.0001
934 INJECTION SITE MASS 2 0.0001
935 MEDICATION ERROR 3 0.0001
936 DYSGEUSIA 4 0.0001
937 HOT FLUSH 4 0.0001
938 COLITIS 2 0.0001
939 CONVULSION 3 0.0001
940 INJECTION SITE SWELLING 4 0.0001
941 INJECTION SITE PAIN 16 0.0001
942 EYE IRRITATION 3 0.0001
943 SURGERY 3 0.0001
944 NO ADVERSE EVENT 9 0.0000
945 VERTIGO 3 0.0000
946 INSOMNIA 13 0.0000
947 CARDIO-RESPIRATORY ARREST 2 0.0000
948 ROAD TRAFFIC ACCIDENT 2 0.0000
949 BLOOD GLUCOSE INCREASED 9 0.0000
950 WITHDRAWAL SYNDROME 2 0.0000
951 HYPOACUSIS 2 0.0000
952 PSORIASIS 6 0.0000
953 ADVERSE DRUG REACTION 4 0.0000
954 SUICIDAL IDEATION 4 0.0000
955 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
956 JOINT SWELLING 5 0.0000
957 EMOTIONAL DISTRESS 5 0.0000
958 HYPOGLYCAEMIA 2 0.0000
959 ABASIA 1 0.0000
960 UNEVALUABLE EVENT 3 0.0000
961 CHRONIC KIDNEY DISEASE 3 0.0000
962 MUSCULOSKELETAL PAIN 2 0.0000
963 DEPRESSED MOOD 2 0.0000
964 INJECTION SITE HAEMORRHAGE 3 0.0000
965 DRY SKIN 5 0.0000
966 CARDIAC FAILURE CONGESTIVE 3 0.0000
967 DRUG EFFECT DECREASED 2 0.0000
968 CONSTIPATION 8 0.0000
969 DRUG DOSE OMISSION 6 0.0000
970 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
971 FLATULENCE 2 0.0000
972 RHEUMATOID ARTHRITIS 4 0.0000
973 INCORRECT DOSE ADMINISTERED 8 0.0000
974 DEATH 29 0.0000
975 DEVICE ISSUE 3 0.0000
976 ALOPECIA 6 0.0000
977 NEOPLASM MALIGNANT 2 0.0000
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
979 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
980 SKIN BURNING SENSATION 2 0.0000
981 ACCIDENTAL OVERDOSE 1 0.0000
982 DEPRESSION 6 0.0000
983 ABNORMAL BEHAVIOUR 1 0.0000
984 ABORTION SPONTANEOUS 1 0.0000
985 BREAST CANCER 2 0.0000
986 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
987 OVERDOSE 3 0.0000
988 ACNE 1 0.0000